THYMUS NEOPLASMS
Clinical trials for THYMUS NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new THYMUS NEOPLASMS trials appear
Sign up with your email to follow new studies for THYMUS NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called TNhYP218 CAR T cells for people with solid tumors that have high levels of a protein called mesothelin, including mesothelioma. Participants' own immune cells are collected, modified in a lab to better attack cancer, and then gi…
Matched conditions: THYMUS NEOPLASMS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Radioactive drug takes on standard therapy for rare lung and thymus cancers
Disease control Recruiting nowThis Phase 3 trial tests whether a radioactive drug called 177Lu-edotreotide works better than the standard drug everolimus for people with advanced neuroendocrine tumors of the lung or thymus. About 170 participants will receive either six cycles of the radioactive therapy or da…
Matched conditions: THYMUS NEOPLASMS
Phase: PHASE3 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC